XML 36 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Business combinations (Tables)
3 Months Ended
Mar. 31, 2022
Business Combinations [Abstract]  
Schedule of Fair Value of PRA Health Sciences Inc Acquisition Consideration
The preliminary Merger Date fair value of the consideration transferred consisted of the following:

 (in thousands)
Fair value of cash consideration$5,308,646 
Fair value of ordinary shares issued to acquiree stockholders5,658,126 
Fair value of replacement share-based awards issued to acquiree employees209,399 
Repayment of term loan obligations and accrued interest *865,800 
$12,041,971 
* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.
Schedule of PRA Health Sciences Inc Acquisition
The following table summarizes the preliminary allocation of the consideration transferred based on management’s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:

July 1,
2021
(in thousands)
Cash and cash equivalents$259,971 
Accounts receivable and unbilled revenue934,308 
Other current assets125,156 
Fixed assets156,851 
Operating lease right-of-use assets181,708 
Goodwill *8,121,468 
Intangible assets4,886,000 
Deferred tax assets28,099 
Other assets33,928 
Accounts payable(50,259)
Accrued expenses and other current liabilities(380,342)
Current portion of operating lease liabilities(37,355)
Unearned revenue(739,278)
Non-current portion of operating lease liabilities(148,037)
Non-current deferred tax liabilities(1,126,950)
Other non-current liabilities(203,297)
Net assets acquired$12,041,971 
* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.
Schedule of Fair Value of Intangible Assets PRA Health Sciences Inc Acquisition
The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):
Estimated Fair ValueEstimated Useful Life
Customer relationship3,915,000 23 years
Order backlog490,000 3 years
Trade names202,000 3 years
Patient database168,000 7 years
Technology111,000 5 years
4,886,000 
Schedule of Proforma Information of PRA Health Sciences Inc Acquisition Consequently, actual future results of the Company will differ from the pro forma financial information presented below:
Three Months EndedThree Months Ended
March 31, 2022March 31, 2021
(in thousands, except per share data)
Revenue$1,901,764 $1,791,973 
Net income (loss)$111,970 $(204,650)